BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Factor Xia

Below is an extended Factor Xia research listing. Click here to return to the Factor Xia main in depth entry.

Recent Publications on Factor Xia:

The elusive physiologic role of Factor XII.
Physiologic hemostasis upon injury involves many plasma proteins in a...
Direct Link
30th August, 2008
Division of Hematology and Oncology, Case Western Reserve University and
Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
Coagulation factor XI (FXI) is a covalent homodimer consisting of two...
Direct Link
20th August, 2008
Sol Sherry Thrombosis Research Center, Temple University School of
Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.
Protein Z (PZ) is a plasma vitamin K-dependent protein that functions as a...
Direct Link
11th July, 2008
Division of Hematology, Washington University, St Louis, MO, USA.
Clavatadine A, A natural product with selective recognition and irreversible inhibition of factor XIa.
Bioassay-guided fractionation of a CH2Cl2/MeOH extract of the sponge...
Direct Link
31st May, 2008
Eskitis Institute, Griffith University, Brisbane, Queensland 4111,
A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets.
The zymogen, factor XI, and the enzyme, factor XIa, interact specifically...
Direct Link
31st May, 2008
Sol Sherry Thrombosis Research Center and Department of Biochemistry,
Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation.
Factor XI is the zymogen of a dimeric plasma protease, factor XIa, with...
Direct Link
21st May, 2008
Department of Pathology, Vanderbilt University, Nashville, Tennessee
A renaissance for the contact system in blood coagulation?
Protein Z (PZ) is a plasma vitamin K-dependent protein that functions as a...
Direct Link
16th May, 2008
Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
In serine proteases, Gly193 (chymotrypsin numbering) is conserved with...
Direct Link
21st March, 2008
UCLA/Orthopaedic Hospital, Department of Orthopaedic Surgery and Molecular
Plasma cholesteryl ester transfer protein and blood coagulability. 27th February, 2008
Dept. of Molecular and Experimental Medicine, The Scripps Research
Factor XIa and tissue factor activity in patients with coronary artery disease.
It has been established that inflammation and enhanced pro-coagulant...
Direct Link
22nd February, 2008
University of Vermont, Department of Biochemistry, Burlington, Vermont,
The role of tissue factor pathway inhibitor-2 in cancer biology.
Tissue factor pathway inhibitor-2 (TFPI-2), a member of the Kunitz-type...
Direct Link
23rd January, 2008
Department of Oncology, Medical University, Bialystok, Poland.
Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats.
The effect of inhibiting activated blood coagulation factor XIa was...
Direct Link
6th December, 2007
Discovery Biology, Bristol-Myers Squibb Company, Pennington, New Jersey
Thrombin-mediated feedback activation of factor XI on the activated platelet surface is preferred over contact activation by factor XIIa or factor XIa. 10781579 9th November, 2007
Macromolecular substrate-binding exosites on both the heavy and light chains of factor XIa mediate the formation of the Michaelis complex required for factor IX-activation.
Binding of factor IX (FIX) to an exosite on the heavy chain of factor XIa...
Direct Link
27th September, 2007
Sol Sherry Thrombosis Research Center, Temple University School of
Functions of AAV-CMV-F.IX And AAV-EF1alpha-F.IX in gene therapy for hemophilia B.
There has been substantial progress in using gene therapy to treat animals...
Direct Link
17th April, 2007
Department of Laboratory Medicine, Faculty of Medicine, Chulalongkorn
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional